These data are consistent with appearance of SLE-like autoimmune disease in mice overexpressing Btk (65, 79), whereas pharmacological inhibition of Btk kinase by PCI-32765 decreased the disease symptoms in several autoimmune models (80). This evidence concerns the gene BTK and systemic lupus erythematosus.